drugset / Trial / NCT03079557
Feasibility Pilot for the ReBOO-trial
Phase 2
Completed
10 enrolled
St. Olavs Hospital
Norwegian University of Science and Technology · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot testing the feasibility of the 'REpurposing BOtulinum Toxin in Treatment of Obesity in Adolescents' trial (ReBOO-trial). The full-scale ReBOO will further investigate safety and efficacy of intragastric injections of botulinum toxin A into the antrum area of the stomach. These injections will be repeated every six months. The study sample will be adolescents with obesity who have not responded to standard conservative treatment.
Timeline
- Start
- 2017-03-14
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |